Efficacy and safety outcomes with remdesivir in COVID-19 patients: A meta-analysis

doi:10.13105/wjma.v9.i1.74

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7706)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

398

WORD

154

HTML

4650

Figures (1-5)

287

Tables (1-4)

273

Sum=5762

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

286

Download

396

Sum=682

Publishing Process of This Article

Item

Count

Browse

466

Download

796

Sum=1262

Feb 28, 2021 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Meta-Anal. Feb 28, 2021; 9(1): 74-87
Published online Feb 28, 2021. doi: 10.13105/wjma.v9.i1.74

Full Size Figure Download Figure

Figure 5 Meta-analytic summary through a fixed-effect model. A: Grade 3 or 4 adverse events data; B: Serious adverse event data.

Citation: Patel TK, Patel PB, Barvaliya M, Vijayalaxmi, Bhalla HL. Efficacy and safety outcomes with remdesivir in COVID-19 patients: A meta-analysis. World J Meta-Anal 2021; 9(1): 74-87
URL: https://www.wjgnet.com/2308-3840/full/v9/i1/74.htm
DOI: https://dx.doi.org/10.13105/wjma.v9.i1.74